Cancer and cognitive changes: The complexity of the problem

Seminars in Oncology Nursing

Volumn 29, Issue 4, 2013, Pages 232-237

  Bender, Catherine M ^a   Thelen, Bethany D ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Cancer; Cancer therapy; Cognitive function; Depression; Symptoms

Indexed keywords

ARTICLE; CANCER THERAPY; CHILD; COGNITION; DEPRESSION; FEMALE; HUMAN; MALE; NEOPLASM; PSYCHOLOGICAL ASPECT; SYMPTOMS;

CANCER; CANCER THERAPY; COGNITIVE FUNCTION; DEPRESSION; SYMPTOMS;

CHILD; COGNITION; FEMALE; HUMANS; MALE; NEOPLASMS;

EID: 84887149441     PISSN: 07492081     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.soncn.2013.08.003     Document Type: Article

References (68)

1. Matlin M.W. Cognition 2003, John Wiley and Sons, New York.
2. Muldoon M., Waldstein S.R., Ryan C.M., et al. Effects of six anti-hypertensive medications on cognitive performance. J Hypertens 2002, 20:1643-1652.
3. Ahles T.A., Saykin A.J., McDonald B.C., et al. Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: impact of age and cognitive reserve. J Clin Oncol 2010, 28:4434-4440.
4. Bender C.M., Sereika S.M., Brufsky A.M., et al. Memory impairments with adjuvant anastrozole versus tamoxifen in women with early stage breast cancer. Menopause 2007, 14:995-998.
5. Hermelink K., Untch M., Lux M.P., et al. Cognitive function during neoadjuvant chemotherapy for breast cancer. Cancer 2007, 109:1905-1913.
6. Jansen C., Cooper B., Dodd M., et al. A prospective longitudinal study of chemotherapy-induced cognitive changes in breast cancer patients. Support Care Cancer 2011, 19:1647-1656.
7. Wefel J.S., Meyers C.A. Cancer as a risk factor for dementia: a house built on shifting sand. J Natl Cancer Inst 2005, 97:788-789.
8. Ahles T.A., Saykin A.J., McDonald B.C., et al. Cognitive function in breast cancer patients prior to adjuvant treatment. Breast Cancer Res Treat 2008, 110:143-152.
9. Minisini A., Atalay G., Bottomley A., et al. What is the effect of systemic anticancer treatment on cognitive function?. Lancet 2004, 5:273-282.
10. Merriman J.D., Von Ah D., Miaskowski C., et al. Proposed mechanisms for cancer- and treatment-related cognitive changes. Semin Oncol Nurs 2013, 29:260-269.
11. Lezak M.D., Howieson D.B., Loring D.W., et al. Neuropsychological assessment. Ed 4 2004, Oxford University Press, New York.
12. Weiss E.M., Kemmler G., Deisenhammer E.A., et al. Sexdifferences in cognitive functions. Pers Individ Dif 2003, 35:863-875.
13. Barrett-Connor E., Laughlin G.A. Endogenous and exogenous estrogen, cognitive function, and dementia in postmenopausal women: evidence from epidemiologic studies and clinical trials. Semin Reprod Med 2009, 27:275-282.
14. Maki P.M., Dumas J. Mechanisms of action of estrogen in the brain: insights from human neuroimaging and psychoparmacologic studies. Semin Reprod Med 2009, 27:250-259.
15. Resnick S.M., Maki P.M. Effects of hormone replacement therapy on cognitive and brain aging. Ann N Y Acad Sci 2001, 949:203-214.
16. Hensley M.L., Peterson B., Silver R.T., et al. Risk factors for severe neuropsychiatric toxicity in patients receiving interferon alfa-2b and low-dose cytarabine for chronic myelogenous leukemia: analysis of Cancer and Leukemia Group B 9013. J Clin Oncol 2000, 18:1301-1308.
17. Weinstein A.A., Deuster P.A., Francis J.L., et al. Neurohormonal and inflammatory hyper-responsiveness to acute mental stress in depression. Biol Psychol 2010, 84:228-234.
18. Cavanaugh S.A., Wettstein R.M. The relationship between severity of depression, cognitive dysfunction, and age in medical inpatients. Am J Psychiatry 1983, 140:495-496.
19. Meijer A., Roseman M., Milette K., et al. Depression screening and patient outcomes in cancer: a systematic review. PLoS One 2011, 6:e27181.
20. Mitchell A.J., Chan M., Bhatti H., et al. Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. Lancet 2011, 12:160-174.
21. Bender C.M., Pacella M.L., Sereika S.M., et al. What do perceived cognitive problems reflect?. J Support Oncol 2008, 6:238-242.
22. Hermelink K., Kuchenhoff H., Untch M., et al. Two different sides of 'chemo-brain': determinants and nondeterminants of self-perceived cognitive dysfunction in a prospective, randomized, multicenter study. Psychooncology 2010, 19:1321-1328.
23. Schagen S.B. Information about chemotherapy-associated cognitive problems contributes to cognitive problems in cancer patients. Psychooncology 2012, 21:1132-1135.
24. Wefel J.S., Saleeba A.K., Buzdar A.U., et al. Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer. Cancer 2010, 116:3348-3356.
25. Jansen C.E., Miaskowski C., Dodd M., et al. A metaanalysis of studies of the effects of cancer chemotherapy on various domains of cognitive function. Cancer 2005, 104:2022-2033.
26. Correa D.D., Hess L.M. Cognitive function and quality of life in ovarian cancer. Gynecol Oncol 2012, 124:404-409.
27. Skaali T., Fossa S.D., Andersson S., et al. Self-reported cognitive problems in testicular cancer patients: relation to neuropsychological performance, fatigue, and psychological distress. J Psychosom Res 2011, 70:403-410.
28. Komaki R., Meyers C.A., Shin D.M., et al. Evaluation of cognitive function in patients with limited small cell lung cancer prior to and shortly following prophylactic cranial irradiation. Int J Radiat Oncol Biol Phys 1995, 33:179-182.
29. Abrey L.E. The impact of chemotherapy on cognitive outcomes in adults with primary brain tumors. J Neurooncol 2012, 108:285-290.
30. Ahles T.A., Saykin A.J. Cognitive effects of standard-dose chemotherapy in patients with cancer. Cancer Invest 2001, 19:812-820.
31. Bender C., Sereika S., Berga S.M., et al. Cognitive impairment associated with adjuvant therapy in women with breast cancer. Psychooncology 2006, 15:422-430.
32. Castellon S.A., Ganz P.A., Bower J.E., et al. Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen. J Clin Exp Neuropsychol 2004, 26:955-969.
33. Collins B., Mackenzie J., Stewart A., et al. Cognitive effects of hormonal therapy in early stage breast cancer patients: a prospective study. Psychooncology 2009, 18:811-821.
34. Shilling V., Jenkins V., Fallowfield L., et al. The effects of hormone therapy on cognition in breast cancer. J Steroid Biochem Mol Biol 2003, 86:405-412.
35. Palmer J.L., Trotter T., Joy A.A., et al. Cognitive effects of tamoxifen in pre-menopausal women with breast cancer compared to healthy controls. J Cancer Surviv 2008, 2:275-282.
36. Schilder C.M., Eggens P.C., Seyaeve C., et al. Neuropsychological functioning in postmenopausal breast cancer patients treated with tamoxifen or exemestane after AC-chemotherapy: cross-sectional findings from the neuropsychological TEAM-side study. Acta Oncol 2009, 48:76-85.
37. Alibhai S., Breunis H., Timilshina N., et al. Impact of androgen-deprivation therapy on cognitive function in men with nonmetastatic prostate cancer. J Clin Oncol 2010, 28:5030-5037.
38. Green H., Pakenham K.I., Headley B.C., et al. Altered cognitive function in men treated for prostate cancer with leutinizing hormone-releasing hormone analogues and cyproterone acetate: a randomized controlled trial. BJU Int 2002, 90:427-432.
39. Cherrier M., Aubin S., Higano C.S. Cognitive and mood changes in men undergoing intermittent combined androgen blockade for non-metastatic prostate cancer. Psychooncology 2009, 18:237-247.
40. Mohile S., Lacy M., Rodin M., et al. Cognitive effects of androgen deprivation therapy in an older cohort of men with prostate cancer. Crit Rev Oncol Hematol 2010, 75:152-159.
41. Bender C.M., Yasko J.M., Kirkwood J.M., et al. Cognitive function and quality of life in interferon therapy for melanoma. Clin Nurs Res 2000, 9:352-363.
42. Valentine A.D., Meyers C.A., Kling M.A., et al. Mood and cognitive side effects of interferon-alpha therapy. Semin Oncol 1998, 25(Suppl 1):39-47.
43. Jing L., Bentzen S.M., Li J., et al. Relationship between neurocognitive function and quality of life after whole-brain radiotherapy in patients with brain metastasis. Int J Radiat Oncol Biol Phys 2008, 71:64-70.
44. Costello A., Shallice T., Gullan R., et al. The early effects of radiotherapy on intellectual and cognitive functioning in patients with frontal and brain tumors: the use of a new neuropsychological methodlogy. J Neurooncol 2004, 67:351-359.
45. Correa D., Shi W., Thaler H., et al. Longitudinal cognitive follow-up in low grade gliomas. J Neurooncol 2008, 86:321-327.
46. Sun A., Bae K., Gore E.M., et al. Phase III trial of prophylactic cranial irradiation compared with observation in patients with locally advanced non-small cell lung cancer: neurocognitive and quality of life analysis. J Clin Oncol 2011, 29:279-286.
47. Cimprich B. Age and extent of surgery affect attention in women treated for breast cancer. Res Nurs Health 1998, 21:229-238.
48. Monk T.G., Weldon B.C., Garvan C.W., et al. Predictors of cognitive dysfunction after major noncardiac surgery. Anesthesiology 2008, 108:18-30.
49. Silverstein J., Steinmetz J., Reichenberg A., et al. Postoperative cognitive dysfunction in patients with preoperative cognitive impairment. Anesthesiology 2007, 106:431-435.
50. American Society of Anesthesiologists. ASA physical status classification system. Available at: (accessed March 12, 2013). http://www.asahq.org/clinical/physicalstatus.htm.
51. Wefel J.S., Vidrine D.J., Veramonti T.L., et al. Cognitive impairment in men with testicular cancer prior to adjuvant therapy. Cancer 2011, 117:190-196.
52. Grosshans D.R., Meyers C.A., Allen P.K., et al. Neurocognitive function in patients with small cell lung cancer. Cancer 2008, 112:589-595.
53. Ahles T.A., Saykin A.J. Candidate mechanisms for chemotherapy-induced cognitive changes. Cancer 2007, 7:192-201.
54. Hare G.M.T. Anaemia and the brain. Curr Opin Anaesthesiol 2004, 17:363-369.
55. Mercadante S., Gebbia V., Marrazzo A. Anemia in cancer: pathophysiology and treatment. Cancer Treat Rev 2000, 26:303-311.
56. Cunningham R.S. Anemia in the oncology patient. Cancer Nurs 2003, 26(Suppl 6):38S-42S.
57. Vardy J.L., Dhillon H., Xu W., et al. Cognitive function and fatigue in colorectal cancer (CRC) patients: baseline assessments prior to chemotherapy [abstr 9557]. J Clin Oncol 2009, 27(Suppl):15s.
58. Cella D., Lai J.-S., Chang C.-H., et al. Fatigue in cancer patients compared with fatigue in the general United States population. Cancer 2002, 94:528-538.
59. Huang X., Zhang Q., Kang X., et al. Factors associated with cancer-related fatigue in breast cancer patients undergoing endocrine therapy in an urban setting: a cross-sectional study. BMC Cancer 2010, 10:453-460.
60. van den Beuken-van Everdingen M.H., de Rijke J.M., Kessels A.G., et al. Prevalence of pain in patients with cancer: a systematic review of the past 40 years. Ann Oncol 2007, 18:1437-1449.
61. Moriarty O., McGuire B.E., Finn D.P. The effect of pain on cognitive function: a review of clinical and preclinical research. Prog Neurobiol 2011, 93:385-404.
62. Sateia M.J., Lang B.J. Sleep and cancer: recent developments. Curr Oncol Rep 2008, 10:309-318.
63. Berger A.M., Parker K.P., Young-McCaughan S., et al. Sleep/wake disturbances in people with cancer and their caregivers: state of the science. Oncol Nurs Forum 2005, 32:99-126.
64. Banks S., Dinges D.F. Behavioral and physiological consequences of sleep restriction. J Clin Sleep Med 2007, 3:519-528.
65. Goder R., Scharffetter F., Aldenhoff J.B., et al. Visual declarative memory is associated with non-rapid eye movement sleep and sleep cycles in patients with chronic non-restorative sleep. Sleep Med 2007, 8:503-508.
66. Daurat A., Terrier P., Foret J., et al. Slow wave sleep and recollection in recognition memory. Conscious Cogn 2007, 16:445-455.
67. Clanton N.R., Klosky J.L., Li C., et al. Fatigue, vitality, sleep, and neurocognitive functioning in adult survivors of childhood cancer: a report from the childhood cancer survivor study. Cancer 2011, 117:2559-2568.
68. Hurria A., Somio G., Ahles T. Renaming "chemobrain.". Cancer Invest 2007, 25:373-377.